Token-Level Transformer improves breast cancer prediction by jointly analyzing genomic and clinical data
Researchers fuse genomic and clinical data at token-level, boosting accuracy for cancer subtypes and survival.
In a new paper on arXiv, researchers Suxing Liu and Byungwon Min introduce a Token-Level Cross-Modal Transformer with Contrastive Multi-Task Learning for breast cancer subtype classification and survival prediction. Existing methods in precision oncology treat genomic and clinical modalities as monolithic feature vectors, preventing fine-grained token-level interactions. They also rely on simple linear weighting or late averaging for cross-modal fusion, and optimize survival and classification objectives independently—missing a joint regularization signal.
The proposed model addresses all three limitations. It processes each modality at the token level, allowing structured token exchange between genomic and clinical data. A contrastive multi-task learning framework jointly optimizes classification and survival prediction, sharing representations across tasks. This approach enables more nuanced patient stratification and survival risk assessment, moving beyond black-box fusion. The work is available on arXiv and represents a step toward more precise, multimodal AI in cancer care. By integrating heterogeneous data at a finer granularity, the model could improve clinical decision-making and personalized treatment planning.
- Introduces token-level interactions between genomic and clinical data instead of monolithic feature vectors.
- Uses structured token exchange rather than linear weighting or late averaging for cross-modal fusion.
- Combines survival prediction and classification objectives in a single contrastive multi-task learning framework.
Why It Matters
Enables more accurate, personalized breast cancer prognosis by jointly analyzing fine-grained genomic and clinical data.